124 related articles for article (PubMed ID: 9625834)
1. Ki-67 antigen expression in relation to clinicopathological variables and prognosis in gastric cancer.
Kikuyama S; Kubota T; Shimizu K; Miyakita M
Oncol Rep; 1998; 5(4):867-70. PubMed ID: 9625834
[TBL] [Abstract][Full Text] [Related]
2. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.
Elpek GO; Gelen T; Aksoy NH; Karpuzoglu T; Keles N
Pathol Oncol Res; 2000; 6(1):59-64. PubMed ID: 10749590
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of cathepsin D and Ki-67 expression at the deepest penetration site for lymph node metastases in gastric cancer.
Goishi H; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncol Rep; 2000; 7(4):713-8. PubMed ID: 10854531
[TBL] [Abstract][Full Text] [Related]
4. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
7. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer.
Mattioli E; Vogiatzi P; Sun A; Abbadessa G; Angeloni G; D'Ugo D; Trani D; Gaughan JP; Vecchio FM; Cevenini G; Persiani R; Giordano A; Claudio PP
J Cell Physiol; 2007 Jan; 210(1):183-91. PubMed ID: 16998811
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the proliferation index in gastric carcinomas with the monoclonal antibody MIB 1.
Broll R; Mahlke C; Best R; Schimmelpenning H; Strik MW; Schiedeck T; Bruch HP; Duchrow M
J Cancer Res Clin Oncol; 1998 Jan; 124(1):49-54. PubMed ID: 9498835
[TBL] [Abstract][Full Text] [Related]
11. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
Lee HE; Mounajjed T; Erickson LA; Wu TT
Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
[TBL] [Abstract][Full Text] [Related]
12. Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer.
de Manzoni G; Verlato G; Tomezzoli A; Guglielmi A; Pelosi G; Ricci F; Di Leo A; Cordiano C
Jpn J Clin Oncol; 1998 Sep; 28(9):534-7. PubMed ID: 9793024
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical assessment of Ki-67 as prognostic cellular proliferation marker in anal canal carcinoma.
Indinnimeo M; Cicchini C; Stazi A; Limiti MR; Ghini C; Mingazzini P; Vecchione A
J Exp Clin Cancer Res; 2000 Dec; 19(4):471-5. PubMed ID: 11277325
[TBL] [Abstract][Full Text] [Related]
14. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
15. L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.
Ichinoe M; Yanagisawa N; Mikami T; Hana K; Nakada N; Endou H; Okayasu I; Murakumo Y
Pathol Res Pract; 2015 Jul; 211(7):533-8. PubMed ID: 25908107
[TBL] [Abstract][Full Text] [Related]
16. Endocrine carcinoma of the stomach: clinicopathological analysis of 27 surgically treated cases in a single institute.
Kubota T; Ohyama S; Hiki N; Nunobe S; Yamamoto N; Yamaguchi T
Gastric Cancer; 2012 Jul; 15(3):323-30. PubMed ID: 22252152
[TBL] [Abstract][Full Text] [Related]
17. Correlation of 15-prostagladin dehydrogenase expression with clinicopathological factors and survival rate in gastric adenocarcinoma.
Seo SH; Kang MS; Kim KH; An MS; Ha TK; Bae KB; Oh MK; Choi CS; Oh SH; Choi YK
Int J Surg; 2015 Jan; 13():96-101. PubMed ID: 25704623
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-2, p53 and Ki-67 in gastric cancer.
Joo YE; Chung IJ; Park YK; Koh YS; Lee JH; Park CH; Lee WS; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
J Korean Med Sci; 2006 Oct; 21(5):871-6. PubMed ID: 17043422
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
20. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]